Pharmafile Logo

IFPMA

Can Cinderella save us?

AMR research ‘under threat’ due to lack of economic incentives

But industry report also shows progress made by the private sector

- PMLiVE

Greg Perry joins IFPMA as assistant director general

Will move to the global industry body from the Medicines Patent Pool

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

Can Cinderella save us?

Motif Bio preps US filing after antibiotic clears phase III

The UK biopharma hopes to launch iclaprim by early 2019

- PMLiVE

Untreatable gonorrhoea on the march worldwide, says WHO

Three people with the STI aren’t responding to last-line antibiotics

- PMLiVE

Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative

- PMLiVE

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

- PMLiVE

Pfizer launches antibiotic resistance surveillance website

Designed for healthcare professional use ATLAS will cover 60 countries

IFPMA appoints director general

Thomas Cueni brings expertise from Interpharma and EFPIA

IFPMA elects Pfizer’s Ian Read as president

Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term

- PMLiVE

Longitude Prize awards grants for antibiotic test development

Five UK teams among the winners seeking to tackle antimicrobial resistance

- PMLiVE

ROAD Comms wins antimicrobial resistance account

Selected by GAMA Healthcare to create infection control campaign

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links